Canadian HTA Ups Industry Fees To Fund Review Process Improvements
Executive Summary
Canada’s health technology appraisal body is to increase its industry fees well beyond inflation for conducting reviews and scientific advice. It says it will also improve its drug reimbursement review process.
You may also be interested in...
Companies Need EU Funding To Cover ‘Enormous Expenditure’ Of Complying With Revised GMP Rules
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.
IGBA Welcomes Mexican Membership
The IGBA has welcomed Mexican pharmaceutical industry association ANAFAM as an associate member.
UK Considers US -Style Payment Reporting Obligations For Drug And Device Firms
The UK pharmaceutical industry association, the ABPI, would like to see its own system strengthened to improve reporting of payments to health care professionals and organizations.